Investigational Site Number: 8260001

London WC1N3JH

3 studies enrolling now · 10 studies all time

What they study most

Alopecia Areata, Asthma, Chronic Obstructive Pulmonary Disease, Crohn's Disease, Gaucher's Disease Type III, Glycogen Storage Disease Type II;Pompe's Disease, Hemophilia A, Systemic Sclerosis, Ulcerative Colitis

Studies at this site

• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis — Recruiting now
• A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata — Stopped early
• Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3 — Running, not enrolling
• Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma — Running, not enrolling
• Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A — Completed
• Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease — Completed
• Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis — Completed